SmarTrend identified a Downtrend for Labopharm (NASDAQ:DDSS) on February 05, 2010 at $2.06. In approximately 1 month, Labopharm has returned 31.1 Read More >>

SmarTrend identified a Downtrend for Labopharm (NASDAQ:DDSS) on February 05, 2010 at $2.06. In approximately 4 weeks, Labopharm has returned 27.7 Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that James R. Howard-Tripp, President and Chief Executive Officer of the Company, will Read More >>

Labopharm Inc. (DDSS)

Expected next earnings release:

Announcement date: 5/6/2010 - Before Market

Earnings Quarter: Q1

Announcement
          
            Read More
            >>
          
        

SmarTrend identified a Downtrend for Labopharm (NASDAQ:DDSS) on February 05, 2010 at $2.06. In approximately 3 weeks, Labopharm has returned 28.6 Read More >>

Labopharm Inc. (DDSS)

Expected next earnings release:

Announcement date: 2/25/2010 - Before Market

Earnings Quarter: Q4

Announcemen
          
            Read More
            >>
          
        

Equedia.com and Equedia Weekly provides research on the top Canadian companies with a focus on TSX and TSX Venture stocks. Equedia is currently resea Read More >>

- Company Preparing for Q3 2010 U.S. Launch of OLEPTRO(TM) -

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today reported its financial re Read More >>

SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:DDS Read More >>

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 25th and determining how th Read More >>

Speciality pharmaceutical company Labopharm Inc (TSX:DDS) (NASDAQ:DDSS) reported on Friday that the underwriters of its recent public offering of newly Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that the underwriters for the recently announced public offering Read More >>

Labopharm, Inc., a Canada-based pharmaceutical company, has raised $20 million in an underwritten public offering of 11,764,706 newl Read More >>

SmarTrend identified a Downtrend for Labopharm (NASDAQ:DDSS) on February 05, 2010 at $2.06. In approximately 2 weeks, Labopharm has returned 23.3 Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the closing of its previously announced underwritten public offerin Read More >>

Labopharm Inc. (DDSS)

Expected next earnings release:

Announcement date: 2/25/2010 - Before Market

Earnings Quarter: Q4

Announcemen
          
            Read More
            >>
          
        

Labopharm Inc. (DDSS)

Expected next earnings release:

Announcement date: 2/25/2010 - Before Market

Earnings Quarter: Q4

Announcemen
          
            Read More
            >>
          
        

(Comment on this article at http://www.financialwire.net/2010/02/16/labopharm-prices-20-million-of-units/)

February 16, 2010 (FinancialWire) -- L Read More >>

- Management to discuss fourth quarter financial results -

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it will host Read More >>

Drug company Labopharm Inc (TSX:DDS) (NASDAQ:DDSS) said on Friday that the company has priced an underwritten public offering of 11,764,706 newly issue Read More >>

SmarTrend identified a Downtrend for Labopharm (NASDAQ:DDSS) on February 05, 2010 at $2.06. In approximately 1 week, Labopharm has returned 23.3% Read More >>

International Forest Products Ltd. (IFP.A.T, C$4.62, C$0.02, 0.4%) posted a fourth-quarter loss of 11 Canadian cents a share, compared Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has priced an underwritten public offering of 11,764,7 Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has commenced an underwritten public offering of up to US Read More >>

Early standouts for Wednesday's trading session include Options Media Group Holdings, Inc. (OTCBB: OPMG), Labopharm Inc. (NASDAQ: DDSS), and Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) ( Read More >>

SmarTrend identified an Uptrend for Labopharm (NASDAQ:DDSS) on December 10, 2009 at $1.82. In approximately 2 months, Labopharm has returned 45% Read More >>

SmarTrend identified an Uptrend for Labopharm (NASDAQ:DDSS) on December 10, 2009 at $1.82. In approximately 1 month, Labopharm has returned 29.1% Read More >>

The editor/analyst of the online investment community Small Cap Network has posted technical outlooks for charts of China Green Agriculture, Inc. (NYSE:CGA), Read More >>

SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:DDS Read More >>

SmarTrend identified an Uptrend for Labopharm (NASDAQ:DDSS) on December 10, 2009 at $1.82. In approximately 1 month, Labopharm has returned 22.5% Read More >>

Canadian pharmaceutical company Labopharm Inc (TSX:DDS) (NASDAQ:DDSS) reported on Friday that it has settled the previously announced draw down of CAD1 Read More >>

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has settled the previously announced draw down of $1 million under its standby equ Read More >>

BeaconEquity.com announces an investment report featuring pharmaceutical company Labopharm Inc. (Nasdaq:DDSS). The report includes financial, compa Read More >>